The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing ...

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots.

Researchers continue to advance the science to determine best treatments for stroke. Based on an international study of 530 patients, researchers discovered that while the clot retrieval procedure ...

Scientists tracked tiny pieces of microplastics as they moved through the brain blood vessels of mice. Some of them became ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

Tumors can drive thrombosis by releasing chemokines, secreted proteins that can circulate to the lung. This image of a lung sample shows how immune cells called macrophages release small vesicles ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

Novartis (NVS) on Tuesday agreed to acquire biopharmaceutical firm Anthos Therapeutics in a deal worth up to $3.1 billion, as the Swiss pharmaceutical giant looks to boost its cardiovascular portfolio ...